Real-world outcomes with ipilimumab and nivolumab in advanced melanoma: a multicentre retrospective study-Reference-Cited by-同舟云学术

Real-world outcomes with ipilimumab and nivolumab in advanced melanoma: a multicentre retrospective study

Published:2022-11 Issue: Volume:176 Page:121-132
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Serra-Bellver Patricio^ORCID,Versluis Judith M.^ORCID,Oberoi Honey K.,Zhou Cong^ORCID,Slattery Timothy D.,Khan Yasir^ORCID,Patrinely James R.^ORCID,Pires da Silva Inês,Martínez-Vila C.,Cook Natalie^ORCID,Graham Donna M.,Carlino Matteo S.,Menzies Alexander M.,Arance Ana M.,Johnson Douglas B.,Long Georgina V.^ORCID,Pickering Lisa^ORCID,Larkin James M.G.,Blank Christian U.,Lorigan Paul^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference24 articles.

1. CheckMate 067: 6.5-year outcomes in patients (pts) with advanced melanoma;Wolchok;J Clin Oncol,2021

2. Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006): post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 study;Robert;Lancet Oncol,2019

3. Five-year survival with combined nivolumab and ipilimumab in advanced melanoma;Larkin;N Engl J Med,2019

4. Combined nivolumab and ipilimumab in melanoma metastatic to the brain;Tawbi;N Engl J Med,2018

5. Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study;Long;Lancet Oncol,2018

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Occult checkpoint inhibitor myocarditis during adjuvant nivolumab plus ipilimumab: a smoldering but severe toxicity;Immunotherapy;2024-09-11

2. Does patient sex affect the treatment outcome of immune checkpoint inhibitors? A Danish, observational melanoma study;European Journal of Cancer;2024-07

3. PROM2 overexpression induces metastatic potential through epithelial‐to‐mesenchymal transition and ferroptosis resistance in human cancers;Clinical and Translational Medicine;2024-03

4. Melanoma—Modern Treatment for Metastatic Melanoma;The Cancer Journal;2024-03

5. Evaluating the efficacy of combination and single-agent immunotherapies in real-world patterns of disease progression and survival of metastatic melanoma patients;Melanoma Research;2024-01-05